Skip to main navigation Skip to search Skip to main content

Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms

Project: Research

Project Details

StatusFinished
Effective start/end date03/6/12 → 09/6/14

Funding

  • Amgen Incorporated: $1,468.00